• Zantac News

    Zantac News

    Recently, the FDA issued an alert to health care professionals and patients regarding the voluntary recall of over-the-counter ranitidine medicines, including the well-known brand, Zantac. As outlined by the FDA, the medicines may contain low levels of a nitrosamine impurity called N-nitrosodimethylamine (NDMA). Patients taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid ingestion and sour stomach, may consider using other OTC products approved for their condition but should consult a health care professional before doing so.

    At GI Associates, patient care and safety is our priority. If you have questions about how this affects you, please contact your gastroenterologist or primary care physician. You may also request an appointment through the patient portal.

    For ongoing updates from the FDA on NDMA in Zactac, visit their website.